Form 4: Merit Medical Director Receives RSU Grant

Director Stephen C. Evans was granted 3,457 restricted stock units under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan.

Summary

• Director Stephen C. Evans received a grant of 3,457 restricted stock units (RSUs) on May 18, 2026.
• The RSUs were issued under the Merit Medical Systems, Inc. 2026 Equity Incentive Plan.
• The grant is subject to continued service to the issuer through the vesting date of May 3, 2027.
• Following this transaction, the director's total beneficial ownership of common stock is 10,266 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.

Positives

• The RSU grant aligns the director's interests with those of shareholders through equity-based compensation.

Negatives

• None noted.

Risks

• Vesting of the RSUs is contingent upon the director's continued service to the company through May 3, 2027.

Future Outlook

The RSUs are scheduled to vest on May 3, 2027, provided the director maintains continued service with the company.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to incentivize long-term oversight and alignment with shareholder value in the medical device sector.

Comparison to Industry Standards

• The use of RSU grants for director compensation is consistent with standard practices among mid-cap medical technology companies.
• The vesting period of approximately one year is a common retention and alignment mechanism in the industry.

Stakeholder Impact

• Shareholders may view the equity grant as a standard alignment of director incentives with company performance.

Next Steps

• Vesting of the 3,457 RSUs on May 3, 2027.

Key Dates

Keywords

Merit Medical Systems, MMSI, Form 4, Director Compensation, Restricted Stock Units, Equity Incentive Plan